BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11285571)

  • 1. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
    Manaresi E; Zuffi E; Gallinella G; Gentilomi G; Zerbini M; Musiani M
    J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S; O'Keeffe G; Kilty C; Doyle S
    J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay.
    Manaresi E; Gallinella G; Zerbini M; Venturoli S; Gentilomi G; Musiani M
    J Med Virol; 1999 Feb; 57(2):174-8. PubMed ID: 9892404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of parvovirus B19 IgG: choice of antigens and serological tests.
    Manaresi E; Gallinella G; Venturoli S; Zerbini M; Musiani M
    J Clin Virol; 2004 Jan; 29(1):51-3. PubMed ID: 14675870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.
    Corcoran A; Mahon BP; Doyle S
    J Infect Dis; 2004 May; 189(10):1873-80. PubMed ID: 15122524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors.
    Manaresi E; Gallinella G; Morselli Labate AM; Zucchelli P; Zaccarelli D; Ambretti S; Delbarba S; Zerbini M; Musiani M
    Epidemiol Infect; 2004 Oct; 132(5):857-62. PubMed ID: 15473148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
    Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
    J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
    Pereira RF; Paula WN; Cubel Rde C; Nascimento JP
    Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED; Rasksen CJ; Christensen J
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
    Chen MY; Lee KL; Hung CC
    J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemiluminescence Western blot assay for the detection of immunity against parvovirus B19 VP1 and VP2 linear epitopes using a videocamera based luminograph.
    Manaresi E; Pasini P; Gallinella G; Gentilomi G; Venturoli S; Roda A; Zerbini M; Musiani M
    J Virol Methods; 1999 Aug; 81(1-2):91-9. PubMed ID: 10488766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.
    Jordan JA
    J Clin Microbiol; 2000 Apr; 38(4):1472-5. PubMed ID: 10747128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
    Kock WC
    J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
    Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
    J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1.
    Musiani M; Manaresi E; Gallinella G; Venturoli S; Zuffi E; Zerbini M
    J Med Virol; 2000 Mar; 60(3):347-52. PubMed ID: 10630969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG.
    Kaikkonen L; Söderlund-Venermo M; Brunstein J; Schou O; Panum Jensen I; Rousseau S; Caul EO; Cohen B; Valle M; Hedman L; Hedman K
    J Med Virol; 2001 Jul; 64(3):360-5. PubMed ID: 11424127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19: ELISA and immunoblot assays.
    Schwarz TF; Roggendorf M; Deinhardt F
    J Virol Methods; 1988 Jun; 20(2):155-68. PubMed ID: 2843558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
    Dembinski J; Eis-Hübinger AM; Maar J; Schild R; Bartmann P
    Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.